Drug Profile
Research programme: human growth hormone - Biolex
Alternative Names: hGH research programme - Biolex; Human growth hormone research programme - BiolexLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Biolex
- Class Growth hormones; Hormonal replacements; Obesity therapies; Recombinant proteins
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Somatotropin deficiency